241 results
Page 4 of 13
8-K
EX-99.2
2jve6hgs
27 Jul 22
Alkermes plc Reports Second Quarter 2022 Financial Results
7:05am
8-K
EX-99.1
wf176oi wudqg9v
7 Jul 22
Alkermes Announces Results of Annual General Meeting of Shareholders
5:20pm
DEFC14A
0f97t880 4m7ket7uj
6 Jun 22
Proxy in contested solicitation
5:29pm
DEFA14A
EX-99.1
lls cnztjq
26 May 22
Additional proxy soliciting materials
6:15pm
8-K
EX-99.1
de8snbgm8 490in
26 May 22
Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors
6:09pm
PREC14A
97z7dbw
26 May 22
Preliminary proxy with contested solicitation
5:29pm
8-K
EX-99.2
lh4rmipfhr0ujdrw
27 Apr 22
Alkermes plc Reports First Quarter 2022 Financial Results
7:07am
8-K
EX-99.1
hvarn0 qsdl5l02
27 Apr 22
Alkermes plc Reports First Quarter 2022 Financial Results
7:07am
DEFA14A
lv3evyx5gd3qg6ypxs
16 Feb 22
Additional proxy soliciting materials
7:17am
8-K
EX-99.2
0cxiy ct8tim
16 Feb 22
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
kdlau7ye64zcnpk wj
16 Feb 22
Results of Operations and Financial Condition
7:05am
DEFA14A
EX-99.2
zk8zrr10jpm8y
11 Jan 22
Additional proxy soliciting materials
7:02am
DEFA14A
EX-99.1
sqdr cn4cc
11 Jan 22
Additional proxy soliciting materials
7:02am
8-K
EX-99.2
pzqd1t6
11 Jan 22
Regulation FD Disclosure
7:00am
8-K
EX-99.1
545wx h3l
11 Jan 22
Regulation FD Disclosure
7:00am
8-K
EX-99.1
jmn9k3tif0kw0w
19 Nov 21
Alkermes Announces the Appointment of Cato T. Laurencin, M.D., Ph.D. to its Board of Directors
7:08am
8-K
EX-99.1
vc7 j61tw
8 Nov 21
Alkermes Announces Receipt of Notices of Partial Termination From Janssen Pharmaceutica
4:17pm